3K0S0GL0U T,STATKEVICH P, JOHNSON LEVONAS AO, etal. Ezetimibe: a review of its metabolism, pharmacokinetics anddrug interactions[ J] . Clin Pharmacokinet, 2005 , 44(5 ) ; 467 -494.
4DAVIS H H. Ezetimibe: first in a new class of cholesterol absorp-tion inhibitors [ J ]. International Congress Series, 2004,1262 :243 -246.
5PANDOR A, ARA R M, TUMUR L, et al. Ezetimibe monothera-py for cholesterol lowering in2722 people: systematic review andmeta - analysis of randomized controlled trials [ J] . Intern Med,2009, 265(5) : 568 -580.
6SCHOUTEN 0,BOERSMA E,HOEKS S E, et al. Fluvastatinand perioperative events in patients undergoing vascular surgery[J]. N Engl J Med, 2009,361(10) : 980 -989.
7LEE C H, DE FEYTER P,SERRUYS P W,et al. Beneficialeffects of fluvastatin following percutaneous coronary intervention inpatients with unstable and stable angina : results from the Lescolintervention prevention study ( LIPS) [ J] . Heart, 2004 , 90(10):1156-1161.
8BALLANTYNE C M. Ezetimibe: efficacy and safety in clinical tri-als [ J ]. Eur Heart J SuppI,2002,4 ( Suppl J) : J9 - J18.
9SAGER P T. Effect of co administration of ezetimibe and simvasta-tin on high - sensitivity C - reactive protein[ J]. Am J Cardiol,2003,92(12) : 1414-1418.
10BALLANTYNE C M, BLAZINGMA, KINGTR, et al. Efficacyand safety of ezetimibe co - administered with simvastatin com-pared with atorvastatin in adults with hypercholesterolemia [ J ].Am J Cardiol,2004, 93(12): 1487 -1494.
